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N-acetylcysteine ameliorates renal microcirculation: Studies in This well documented effect traditionally has been at-
rats. tributed to the restoration of intracellular glutathione
Background. N-acetylcysteine (NAC) administration has levels [2–4], required for detoxification of an acetamino-been shown to ameliorate experimental acute renal failure
phen-derived toxic metabolite. There are indications ofinduced by ischemia-reflow, and was found to prevent radio-
NAC-associated nonspecific amelioration of liver dam-contrast nephropathy in high-risk patients. While the protective
effect of NAC has been primarily attributed to scavenging age from other causes as well, such as warm ischemia-
oxygen free radicals, improving renal microcirculation also may reflow injury [5], cold ischemia-reperfusion in rats [6]
play a role in the prevention of acute renal failure. (but not in humans during liver transplantation [7]), liverMethods. This study was designed to explore the effect of
injury from Amanita toxin [8] and CCl4 [9].NAC on renal microcirculation. Blood pressure, total renal
N-acetylcysteine also may attenuate the course of hep-blood flow and selective regional cortical and outer medullary
blood flow were continuously monitored in anesthetized atorenal syndrome, a renal vasoconstrictive response of
Sprague Dawley rats with ultrasonic and laser-Doppler probes indeterminate nature that develops during advanced
during the infusion of NAC (60 mg/kg). liver failure. This effect, shown in experimental settingsResults. In control intact rats blood pressure and renal mi-
[9] and in a preliminary clinical report [10], could implycrocirculation were unaffected by NAC. By contrast, follow-
a better preservation of liver function. However, directing renal vasoconstriction induced by the radiocontrast agent
iothalamate meglumine, NAC decreased total, cortical and renal protective mechanisms may play a role also, consid-
medullary vascular resistance by 7 to 10% (P  0.05). NAC ering the ubiquitous distribution of acylases that catalyze
also reduced renal vascular resistance by 16% when given the deacetylation of NAC [11]. Indeed, recent studies
during angiotensin II infusion (P  0.05). Altered renal micro-
suggest that NAC may increase intracellular glutathionecirculation, induced by the cyclooxygenase inhibitor indometh-
and ameliorate renal ischemia-reflow injury [12–14], in-acin, by the nitric oxide synthase-inhibitor, Nnitro-l-arginine
(L-NAME), or with their combination was partially restored ferior vena cava-occlusion [15] or kidney damage from
by NAC. Nevertheless, NAC administration failed to attenuate cis-platinum [16], cyclosporine [17], and other nephro-
renal function and morphology in a rat model of acute renal toxic insults [18, 19]. NAC has been reported recently to
failure with selective outer medullary hypoxic injury, induced prevent radiocontrast nephropathy in high-risk patientsby indomethacin, L-NAME and iothalamate.
[20]. These studies, conducted in a clinical trial withoutConclusions. NAC ameliorates renal vasoconstriction, an
preliminary experiments in animals, underscore theeffect that seems to be mediated by mechanisms other than
prostaglandins and nitric oxide. The potential renoprotective safety of oral NAC administration.
outcome of NAC and the role of its vasodilating effect on the As stated above, the mechanism of NAC-related organ
pre-constricted renal vasculature should be evaluated further. protection is primarily attributed to scavenging oxygen
free radicals, either directly, or through increasing intra-
cellular glutathione concentration [3, 4]. Indeed, decreased
N-acetylcysteine (NAC) is a simple and inexpensive malonaldehyde production indicates an attenuation of
water-soluble molecule that contains a sulfhydryl residue. membrane damage from oxygen-free radicals [3], but
It has long been approved for the prevention of hepatic other protective mechanisms may play a role as well [21].
and renal damage following acetaminophen overdose [1]. Improved local microcirculation may be a major poten-
tial NAC-related organ-protective mechanism. NAC was
reported to augment papillary flow [22] and was found toKey words: N-acetylcysteine, kidney, hemodynamics, radiologic con-
trast media, prostaglandins, nitric oxide, vasoconstriction. improve renal vasodilation in response to acetylcholine
[15]. Thus, perhaps some of the protective effects ofReceived for publication April 23, 2002
NAC can be attributed to improved glomerular hemody-and in revised form August 27, 2002
Accepted for publication October 1, 2002 namics or to the prevention of hypoxic tubular damage
via restoration of altered renal microcirculation. 2003 by the International Society of Nephrology
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The current series, therefore, was designed to evaluate dose applied by Comesa et al to improve renal microcir-
culation following inferior vena cava occlusion [15], wasthe effect of NAC on renal hemodynamics.
about twice the total cumulative oral dose used by Tepel
et al in humans [20]. In a few preliminary studies smaller
METHODS
doses (10 and 20 mg/kg) failed to exert substantial hemo-
Sprague-Dawley male rats (weighing 398  6 g) were dynamic responses.
used for all of the experiments, and were fed regular rat The effects of NAC were determined in the following
chow and water ad libitum. The study was conducted in experimental settings:
accord with the NIH Guide for the Care and Use of Labora-
tory Animals (Bethesda, MD, USA). Chemicals were pur- (1) In intact rats (N  15);
chased from Sigma Chemical Co. (St. Louis, MO, USA). (2) In rats pre-treated with agents that alter renal
hemodynamics: (a) 15 minutes after the radiocon-
Hemodynamic studies
trast iothalamate meglumine 60% (CM, 4 mL/kg
As previously described [23], rats were anesthetized IV (N 11); and (b) During low-dose IV infusion
with thiobutabarbital (Inactin, 100 mg/kg IP), and cathe- of angiotensin II (Ang II; starting at a rate of 5
ters were placed in the trachea (PE-250), external jugular ng/kg/min with the dose increased as needed to
vein, femoral artery and vein (PE-50). Bovine serum achieve moderate renal vasoconstriction with mini-
albumin (4 mg/dL; BSA) in saline was infused through- mal effect upon blood pressure; N  6);
out the experiment (5 mL/h) and mean arterial blood (3) In rats treated with inhibitors of renal vasodila-
pressure (MAP) was continuously monitored by a pres- tion: (a) 15 minutes following non-selective cyclo-
sure transducer system connected to the arterial line. oxygenase (COX) inhibition with indomethacin
The left kidney was exposed through a midline incision, (INDO, 10 mg/kg IV, N  13); (b) 15 minutes
decapsulated, and mechanically fixed. The rat core and following nitric oxide synthase (NOS) inhibition
renal temperatures were monitored and maintained at with Nnitro-l-arginine methyl ester (L-NAME,
approximately 37C with a heating lamp and intermittent 10 mg/kg IV, N  14); (c) 15 minutes following
dripping of warm saline and paraffin oil. The urinary both COX and NOS inhibition (N  11). In this
bladder was incised to prevent urinary retention. group the animals were first given indomethacin
A perivascular transonic ultrasonic volume flow sensor or L-NAME, followed by NAC. Thirty minutes
(T-106; Transonic Systems Inc., Ithaca, NY, USA) moni- later, L-NAME or indomethacin were supple-
tored renal blood flow, with the probe mounted on the mented, respectively, with an additional dose of
left renal artery. Regional blood flows were measured NAC 15 minutes later.
using laser-Doppler probes connected to flow meters
Complementary studies(models PF2B and PF3; Perimed, Stockholm, Sweden).
A superficial probe (1 mm diameter) monitored cortical To further explore a potential role of prostaglandins
blood flow, while a needle probe (0.45 mm diameter) was and nitric oxide (NO) in NAC-induced vasodilation, pros-
inserted at a depth of 4.5 to 5.0 mm, for the determination taglandin E2 (PGE2) was determined, as previously de-
of changes in outer medullary blood flow. Its proper place- scribed [24], in renal cortical homogenates, harvested 10
ment within the outer medulla was confirmed macro- minutes after the administration of NAC (60 mg/kg IV)
scopically at the conclusion of the experiment. or its saline vehicle to 12 anesthetized rats.
On-line recordings of hemodynamic studies were Intrarenal NO was determined following NAC admin-
stored, displayed and analyzed with the use of a compu- istration in few additional rats with a selective NO elec-
terized system (MacLab/8; Analog Digital Instruments, trode (Inter Medical, Tokyo, Japan), inserted into the
Pty Ltd, Castle Hill, NSW, Australia). Mean values for renal cortex, as previously detailed [25]. The electrode
each determinant were analyzed over one to five minute current was calibrated with the NO donor SNAP (100
periods. Total renal, cortical and medullary vascular re- pA roughly representing 0.19 mol/L of SNAP).
sistances were calculated from the changes in blood pres-
Acute renal failure modelsure and the corresponding blood flows. All values are
expressed as the percentage of baseline measurements. In a complementary study, the potential renoprotec-
tive effect of NAC was evaluated in a rat model of acute
Experimental design renal failure with selective outer medullary hypoxic tubu-
Studies were initiated following a 30-minute stabiliza- lar injury, induced by the combined effects of L-NAME
tion period. (10 mg/kg IV), indomethacin (10 mg/kg IV) and the radio-
N-acetylcysteine 60 mg/kg, diluted to a final volume contrast iothalamate meglumine 60% (6 mL/kg IA) [24].
of 0.5 mL, was infused intravenously over three minutes. Rats were randomized to receive NAC or saline (con-
trols), administered IP repeatedly at 24 and 12 hoursThe NAC dose chosen, though much smaller than the
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Table 1. Effects of pre-treatment and NAC upon calculated renal vascular resistance
Maximal effect of NAC
Effect of preconditioning change from
change from baseline post–preconditioning
Preconditioning Vascular bed studied % P % P
Intact animals (N  15) Total renal — 31% NS
Cortical — 31% NS
Medullary — 53% NS
Radiocontrast (CM) (N  11) Total renal 1311% NS 92% 0.05
Cortical 81% 0.01 103% 0.05
Medullary 1919% NS 72% 0.05
Angiotensin II (N  6) Total renal 5519% 0.01 164% 0.05
Cortical 217% 0.01 64% NS
Medullary 41% 0.05 62% 0.05
Indomethacin (INDO) (N  13) Total renal 14% NS 133% 0.001
Cortical 03% NS 112% 0.001
Medullary 489% 0.001 112% 0.001
L-NAME (N  14) Total renal 15032% 0.001 103% 0.05
Cortical 10021% 0.001 104% 0.05
Medullary 21229% 0.001 65% NS
INDO  L-NAMEa (N  11) Total renal 12951% 0.01 284% 0.001
Cortical 7931% 0.01 195% 0.001
Medullary 18760% 0.001 164% 0.001
Changes in total renal and selective cortical and outer medullary vascular resistance were calculated by dividing the changes in blood pressure with the corresponding
changes in blood flow. The effects of preconditioning and of the subsequent NAC administration are separately calculated, with the corresponding statistical significance
(P values, paired t test).
a Animals in this group were preliminarily given INDO or L-NAME, followed by NAC. Subsequently, they were administered with either L-NAME or INDO,
followed by a repeated NAC challenge. The intermediate dose of NAC explains the somewhat lower effect of preconditioning, as compared to L-NAME alone.
Without it, the combined impact of indomethacin and L-NAME upon renal vasoconstriction would have been most intense [40].
and 30 minutes prior to, and four to six hours after the counted. Papillary necrosis was semiquantitatively as-
sessed using a 0 to 3 scale as previously detailed [26].induction of the acute renal failure (ARF) protocol. NAC
was given at a low (20 mg/kg) or a high (60 mg/kg) dose.
StatisticsThe rats (307 6 g) were kept in metabolic cages with
Data are presented as means  SEM. The statisticalfree access to standard rat chow and water. Following a
significance of changing hemodynamic parameters, ex-baseline 24-hour collection period (day 0, during which
pressed as the change from baseline measurements, waspre-treatment with either NAC or saline was initiated),
assessed using one-way analysis of variance (ANOVA).they were anesthetized with pentobarbital (40 mg/kg IP).
Two-way ANOVA was applied for comparison of re-The femoral artery and vein were cannulated with poly-
peated renal function tests in the control and NACethylene catheters for drug administration, baseline plasma
groups subjected to the renal failure protocol. The Stu-samples were obtained, and the rats were subjected to
dent t test was used for the comparison of morphologicindomethacin, L-NAME and radiocontrast medium (CM).
findings and prostaglandin concentrations, and simpleThe rats were allowed to recover in the metabolic cages
correlation was applied as indicated. Statistical signifi-for an additional 24 hours, and then anesthetized with
cance was set at P  0.05.Inactin (50 mg/kg). A second set of urine and plasma
samples were obtained (day 1 period) and the kidneys
RESULTSwere perfusion-fixed in vivo with glutaraldehyde for
morphologic evaluation as previously detailed [23, 24]. Hemodynamic studies
The kidneys were post-fixed in buffered 2% OsO4, dehy- In control, untreated animals, mean blood pressure
drated, and embedded in an Araldite-EM bed 812 mix- (99  3 mm Hg) and renal microcirculation (total renal
ture. Large sections were cut perpendicular to the renal blood flow 10.1  0.9 mL/min) were not affected by the
capsule, containing cortex and medulla. Sections (1 m) administration of NAC (Table 1 and Fig. 1).
were analyzed in a blinded fashion for morphologic alter- By contrast, 15 minutes following iothalamate [that
ations. Tubular necrosis was determined separately for compromised both total renal (13  5%) and cortical
S3 proximal tubules in the outer stripe and for medullary (15  4%) blood flows] [27], NAC improved renal
thick limbs (mTALs) in the outer, middle and inner zones microcirculation, reducing calculated total renal, cortical
(A, B and C zones, respectively) of the inner stripe of and outer medullary vascular resistances (Table 1 and
the outer medulla. The extent of damage was expressed Fig. 2).
In animals continuously infused with low-dose Ang IIas the percentage of necrotic tubules out of total tubules
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Fig. 1. Renal hemodynamic effects of N-acetylcysteine (NAC). NAC (60 mg/kg over 3 min) was injected to untreated anesthetized rats (CTR),
and to animals pre-treated with indomethacin (INDO, 10 mg/kg), Nnitro-l-arginine methyl ester (L-NAME, 10 mg/kg), or their combination
(INDONAME). Data are shown as the change from baseline values just before NAC administration. (A) Blood pressure. (B) Total renal blood
flow and renal vascular resistance. (C ) Cortical microcirculation. (D) Outer medullary microcirculation. In the INDONAME group the agents
were given 45 minutes apart, with two NAC doses injected 15 minutes after each agent. Data presented are following the second dose. (Note that
the effects of L-NAME or indomethacin on renal hemodynamics are prolonged and extend beyond 90 minutes. By contrast, as shown in Figures
2 and 3, the effect of NAC wanes over time, yet, the more prominent response might reflect the double dose). Symbols are: () intact rats, N 
15; () post-INDO, N  13; () post–L-NAME, N 14; () post–L-NAMEINDO, N 11; *P 0.01, **P 0.05 vs. baseline, one-way ANOVA.
(reducing renal blood flow by 29 7%, with blood pres- by 26  4%), NAC improved total, cortical and medul-
lary flows (Table 1 and Fig. 1).sure hardly affected at 4  5%), NAC ameliorated
total renal vascular resistance (Table 1 and Fig. 3). In animals subjected to L-NAME, renal vasoconstric-
tion [occurring both in the cortex (flow reduction 33 In animals given indomethacin (which, as previously
noted [24, 28] selectively reduced medullary blood flow 5%) and outer medulla (38  5%)] [28] was partially
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Fig. 3. Hemodynamic effects of NAC in animals infused with angioten-
sin II (Ang II). NAC (60 mg/kg over 3 min) was injected to anesthetized
rats, continuously infused with Ang II (5 to 25 ng/kg/min). Symbols
are: () determined blood pressure and flows; () calculated vascular
resistance; *P  0.01 vs. baseline, one-way ANOVA.
buffered saline (PBS) solution in vitro increased the NO
readings roughly by 350 pA per 1 mmol/L of NAC.
Acute renal failure model
In a rat model of acute renal failure with selective
outer medullary hypoxic injury, plasma creatinine and
urea rose three- to fivefold, respectively, and creatinine
Fig. 2. Hemodynamic effects of NAC in animals subjected to radiocon-
clearance declined proportionally (N  12, P  0.001;trast. NAC (60 mg/kg over 3 min) was injected to anesthetized rats 15
minutes after the administration of iothalamate meglumine 60% (CM, Table 2). Hypoxic damage was noted predominantly in
4 mL/kg IV, N  11). Symbols are () determined blood pressure and the mid-inner stripe, affecting 10  5% of medullary
flows; () calculated vascular resistance; *P  0.01 vs. baseline, one-
thick limbs (mTALs). Focal proximal tubular necrosisway ANOVA.
in the outer stripe and papillary tip necrosis were de-
tected as well. The administration of NAC somewhat
lowered baseline plasma urea (P  0.04), but a trendattenuated by NAC. Blood pressure that increased 25 
toward lower plasma urea and creatinine levels at day 14% with L-NAME was partially attenuated also (Table
fell short of statistical significance (P  0.18 and P 1 and Fig. 1).
0.09, respectively, ANOVA). Final creatinine clearanceIn animals subjected to both indomethacin and L-NAME
also did not improve with NAC administration. More-the vasodilatory response to NAC was most pronounced,
over, the extent of tubular damage tended to increasealbeit partial (Table 1 and Fig. 1).
in animals subjected to NAC. None of these differences
were statistically significant (Table 2).Complementary studies
Overall, functional deterioration poorly correlatedProstaglandin E2, determined in renal cortical homog- with structural damage, with the only nearly significantenates 10 minutes after the administration of NAC (60
association being the extent of mTAL necrosis in B zonemg/kg IV) was 5.6  1.4 ng/g wet weight, comparable to
and final plasma creatinine (R  0.32, P  0.09). Note-6.7  1.5 ng/GWW, determined in animals subjected to
worthy, papillary injury score inversely correlated with
the saline vehicle (N  6 per group). mTAL necrosis (R  0.38, P  0.03).
N-acetylcysteine injection (60 mg/kg IV) markedly in-
creased renal cortical NO readings, from baseline values
DISCUSSIONof 25,800 3467 pA to 47,775 3791 pA at four minutes,
with subsequent readings gradually declining (N  4, The nature of NAC-associated renal protection is
P  0.002). However, pre-treatment with L-NAME did thought to be predominantly mediated by its antioxida-
not prevent the surge in NO readings, which increased by tive properties. This series of experiments explored an-
other putative mechanism of renal protection by NAC,12,700 300 pA. Moreover, NAC added to a phosphate-
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Table 2. Kidney function and morphology in animals subjected to ARF protocol
Group (N )
CTR (12) NAC-low (6) NAC-high (19)
Urine volume mL/h Baseline 0.450.05 0.700.09 0.490.04
Day 1 0.800.19 0.780.18 0.510.05
Plasma urea mmol/L Baseline 6.20.2 6.00.2 5.40.2c
Day 1 30.63.0a 25.24.9a 25.42.3a
Plasma creatinine lmol/L Baseline 483 392 462
Day 1 13116a 1049a 1007a
Creatinine clearance mL/min/100 g weight Baseline 0.460.04 0.670.11 0.450.03
Day 1 0.170.03a 0.230.05a 0.160.01a
Tubular sodium reabsorption % Baseline 99.640.03 99.590.03 99.600.03
Day 1 95.523.23 98.950.22b 99.170.11a
S3 necrosis % of tubules 3.21.3 6.83.2 8.74.0
mTAL necrosis % of tubules A Zone 0 0 1.00.9
B Zone 10.04.8 16.28.8 19.46.7
C Zone 0 0.40.4 1.81.1
Papillary damage score (0–3 scale) 1.00.3 0 0.60.2
Rats administered with indomethacin (10 mg/kg), L-NAME (10 mg/kg) and sodium iothalamate 60% (6 mL/kg) were randomized to receive 4 intraperitoneal
injections of saline (controls, CTR), low-dose NAC (20 mg/kg, NAC-low) or high-dose NAC (60 mg/kg, NAC-high) before and throughout the induction of the
ARF protocol. Functional determinants were determined at baseline and during the subsequent 24 hours. Renal morphology was determined at 24 hours.
a P  0.01, b P  0.05 vs. baseline (paired t test)
c P  0.03 vs. CTR (ANOVA)
namely renal vasodilation. Such an effect, suggested by hibition [15]. Other mechanisms, including alterations
of the renin-angiotensin system [36–39] or endothelial-Safirstein, Andrade and Vieira [21], is especially appeal-
ing in the perspective of a preliminary report about NAC derived hyperpolarizing factor also may be involved.
Whatever the mechanism, the absence of hemodynamiceffectiveness in patients with the hepato-renal syndrome
[10], a condition characterized by intense renal vasocon- alterations in response to NAC in intact animals indicate
that preceding vasoconstriction may be required for NACstriction in the absence of structural damage. This con-
cept has been supported recently by a report of NAC to induce renal vasodilation. Interestingly, the most prom-
inent NAC-related vasodilatory effect was noted in ani-ameliorating compromised renal microcirculation follow-
ing inferior vena cava occlusion [15]. Indeed, our hemo- mals subjected to both COX and NOS inhibition (Fig. 1).
This combined treatment induces a most intense renaldynamic studies confirm that NAC can partially reverse
renal vasoconstriction induced by radiocontrast and Ang vasoconstriction [40], possibly blunted in our current
studies (Table 1) by the administration of the intermedi-II, or during the inhibition of renal PG or NO production.
Moreover, these later studies indicate that NAC-induced ate dose of NAC.
A complementary set of experiments was designed torenal vasodilation may be mediated through mechanisms
other than NO and PGs. test the protective potential of NAC in an experimental
model of ARF induced by the inhibition of prostaglandinRenal cortical PGE2 was not affected by NAC at the
time when hemodynamic responses to NAC were ex- and NO production, in conjunction with the administra-
tion of the radiocontrast iothalamate meglumine. All threepected to be maximal. The increased readings with an
NO electrode following NAC infusion probably reflect insulting components in this model markedly aggravate
the physiologic medullary hypoxia [41]. Indeed, theira nonspecific current response to NAC, as indicated from
the complementary in vitro assay. NAC does not serve combined administration results in a selective medullary
hypoxic damage, predominantly affecting the mTALs inas a nitric oxide donor. Moreover, peak NO readings
occurred at four minutes while renal hemodynamics re- the inner stripe of the outer medulla [27]. It is postulated
that a decline in regional blood flow and oxygen supplymained stable, and this was not prevented by L-NAME.
Thus, the mechanisms of NAC-induced vasodilation re- (through the inhibition of NO and prostaglandin forma-
tion), combined with enhanced oxygen consumption formain obscure. Prostaglandins, and particularly NO, still
may play a role, as suggested by NAC-related complex tubular reabsorption (the consequence of radiocontrast-
related osmotic diuresis), leads to regional oxygen depri-effects on NOS and on COX at different NAC concentra-
tions and experimental settings [28–33]. Moreover, changes vation and hypoxic damage [42].
In this animal model, a trend toward attenuation ofin cGMP-related vasorelaxation may involve post-tran-
scriptional modulation of NO availability [34, 35]. In- the decline in kidney function with the administration
of NAC did not reach statistical significance. This disap-deed, NAC-induced vasodilation following renal ische-
mia was recently reported to be attenuated by NOS in- pointing finding could reflect a type 2 error (groups too
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small to detect a statistical significance). However, de- compromised renal circulation in this ARF model. Per-
haps a more modest renal vasoconstriction may be betterspite somewhat lower final plasma creatinine and urea
levels in the NAC-treated animals, there was a trend attenuated by NAC in clinical practice.
Intraperitoneal injection of a large amount of NACtoward a more pronounced medullary hypoxic damage,
both in S3 segments and mTALs in the outer medulla, (10 times our dose) has been reported to induce a rapid
accumulation of intraperitoneal fluids with subsequentand in the papilla.
As indicated from Table 1, this animal model is charac- effective volume depletion, and even to a paradoxical
decline of tissue glutathione [48]. Hemodynamic instabil-terized by intense renal vasoconstriction (related to the
inhibition of prostaglandin and NO synthesis in the outer ity due to volume depletion seems unlikely in our study,
using low-dose diluted NAC, considering the low base-medulla), which we expected to be attenuated by NAC.
How, then, this paradox can be explained? The clinical line plasma urea in our NAC-treated animals.
Finally, we have previously noted some inverse corre-syndrome of “acute tubular necrosis” may represent both
pre-renal components that lead to altered glomerular lation between outer stripe and papillary tip damage
hemodynamics and diminished glomerular filtration, as (S. Rosen, unpublished data). It is the first time this
well as to definable structural injury. Because of the correlation is being looked at statistically. This may re-
reversibility of sub-lethal damage, tissue sampling prob- flect an upstream attenuation of tubular reabsorptive
lems, and biopsy timing, it is impossible to gauge the activity in distally obstructed nephrons [49]. Alterna-
contribution of the structural injury to the evolution of tively, this may reflect different or perhaps competitive
renal failure in humans. Augmentation of glomerular distribution of blood supply at the level of the papilla
filtration usually would be considered a positive attribute and the outer medulla [50].
of drug therapy. However, if this occurs under circum- In conclusion, intravenous NAC (60 mg/kg) has no
stances in which medullary blood flow and oxygenation hemodynamic effects in intact rats, but it ameliorates
are not concomitantly augmented, tubular hypoxic dam- renal vasoconstriction induced by radiocontrast, Ang II,
age may develop subsequently [43]. This concept has indomethacin and L-NAME. NAC-induced renal vaso-
been shown under experimental settings [44] and, in- dilation is greatest following the most intense vasocon-
deed, numerous clinical studies have failed to demon- strictive maneuvers. NAC-associated vasodilating effect
strate a salutary effect of renal vasodilating agents (such on the pre-constricted renal vasculature seems to be me-
as dopamine or ANP analogs) during the evolution of diated by mechanisms other than prostaglandins and ni-
acute renal failure. Thus, in the experimental setting, tric oxide.
NAC-induced cortical vasodilation and enhanced glo- These findings suggest that NAC-related protective
merular filtration might augment the distal tubular reab- properties during the evolution of acute renal failure
sorptive workload, not fully compensated with enhanced may be mediated in part by vasodilation of constricted
oxygen supply, and lead to a subsequently intensified renal vasculature.
distal tubular damage.
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